|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to operating cash flows | |||||
| Depreciation, accretion and amortization | |||||
| Provision for credit losses (recoveries) | |||||
| Share-based payments and settlements | |||||
| Net change in equity securities at fair value | |||||
| Net realized (gains) losses on available-for-sale investments | |||||
| Net (gains) losses on other real estate owned | |||||
| (Increase) decrease in carrying value of equity method investments | |||||
| Dividends received from equity method investments | |||||
| Net other non-cash movements | |||||
| Changes in operating assets and liabilities | |||||
| (Increase) decrease in accrued interest receivable and other assets | |||||
| Increase (decrease) in employee benefit plans, accrued interest payable and other liabilities | |||||
| Cash provided by (used in) operating activities | |||||
| Cash flows from investing activities | |||||
| Net (increase) decrease in securities purchased under agreements to resell | |||||
| (Increase) decrease in securities purchased under agreements to resell having original maturities of 3 months of less | |||||
| Securities purchased under agreements to resell having original maturities of more than 3 months: proceeds from maturities | |||||
| Short-term investments other than restricted cash: proceeds from maturities and sales | |||||
| Short-term investments other than restricted cash: purchases | |||||
| Available-for-sale investments: proceeds from sale | |||||
| Available-for-sale investments: proceeds from maturities and pay downs | |||||
| Available-for-sale investments: purchases | |||||
| Held-to-maturity investments: proceeds from maturities and pay downs | |||||
| Held-to-maturity investments: purchases | |||||
| Net (increase) decrease in loans | |||||
| Additions to premises, equipment and computer software | |||||
| Proceeds from sale of other real estate owned | |||||
| Purchase of intangible assets | |||||
| Cash provided by (used in) investing activities | |||||
| Cash flows from financing activities | |||||
| Net increase (decrease) in deposits | |||||
| Net increase (decrease) in securities sold under agreements to repurchase | |||||
| Repayment of long-term debt | |||||
| Common shares repurchased | |||||
| Cash dividends paid on common shares | |||||
| Cash provided by (used in) financing activities | |||||
| Net effect of exchange rates on cash, cash equivalents and restricted cash | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash: beginning of year | |||||
| Cash, cash equivalents and restricted cash: end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash interest paid | |||||
| Cash state income taxes paid, including: | |||||
| Canada | |||||
| Guernsey | |||||
| Jersey | |||||
| Total cash state income taxes paid, including: | |||||
| Supplemental disclosure of non-cash items | |||||
| Transfer to (out of) other real estate owned | |||||
| Transfer of available-for-sale investments to held-to-maturity investments | |||||
| Initial recognition of right-of-use assets and operating lease liabilities | |||||
| Components of cash, cash equivalents and restricted cash at end of year | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in short-term investments on the consolidated balance sheets | |||||
Loading...